3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
3
Myeloid
2
Lymphoid
1
Genitourinary
1
Classical hematology
1
Conditions
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Acute
2
Neutropenia
1
Myeloproliferative Disorders
1
Interventions
fludarabine
63
Cyclophosphamide
63
venetoclax
57
Azacitidine
52
fludarabine phosphate
50
Specimen Handling
44
Whole-Body Irradiation
40
ruxolitinib
37
Mycophenolic Acid
37
Tacrolimus
35
Melphalan
32
Busulfan
32
Biopsy
32
Cytarabine
31
Stem Cell Transplantation
27
Decitabine
27
Granulocyte Colony-Stimulating Factor
21
asciminib
19
decitabine and cedazuridine drug combination
18
Sirolimus
18
Peripheral Blood Stem Cell Transplantation
18
Injections
18
Thiotepa
17
Filgrastim
17
nilotinib
15
X-Rays
14
Methotrexate
14
Cyclosporine
14
Imatinib Mesylate
13
Magnetic Resonance Spectroscopy
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Levofloxacin
×
Myeloid
×
1 year
×
Clear all
NCT07528417
2026-04-22
MYELO-CAN:ABX
University of Manitoba
Phase 2
Not yet recruiting
75 enrolled
NCT03594149
2026-01-02
AZABAC
Centre Henri Becquerel
Phase 3
Completed
60 enrolled